However, to support this proposition, the quantitative results of BCL2A1 expression, as measured by QuPath, must align with findings from previous studies on the stage and grade of acute HCA based on neutrophil infiltration. The gene discussed is BCL2A1; the disease is hepatocellular adenoma.